Lynx1 Capital Management LP reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dorado
SEC filing record 1 source field available
Fiscal year end
31 December
Lynx1 Capital Management LP has filed 126 SEC EDGAR filings since 14 Feb 2022

SEC filing history

Showing 101-125 of 126 matching filings.

Per page
25
Current page
5
SC 13G/A

BIONOMICS LIMITED

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-22151

13F-HR filing

Filing date
14 Nov 2023
Reporting date
30 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

C4 THERAPEUTICS, INC.

Filing date
13 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

STOKE THERAPEUTICS, INC.

Filing date
06 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

BIONOMICS LIMITED

Filing date
30 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-22151

13F-HR filing

Filing date
14 Aug 2023
Reporting date
30 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40603

4 filing

Filing date
02 Jun 2023
Reporting date
31 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-40603

3 filing

Filing date
02 Jun 2023
Reporting date
31 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

TSCAN THERAPEUTICS, INC..

Filing date
02 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-22151

13F-HR filing

Filing date
15 May 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

CABALETTA BIO, INC.

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

PASSAGE BIO, INC.

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

PIERIS PHARMACEUTICALS, INC.

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

ALPINE IMMUNE SCIENCES, INC.

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-22151

13F-HR filing

Filing date
14 Feb 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

KINNATE BIOPHARMA INC.

Filing date
23 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

PARDES BIOSCIENCES, INC.

Filing date
23 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

NEOLEUKIN THERAPEUTICS, INC.

Filing date
30 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-22151

13F-HR filing

Filing date
14 Nov 2022
Reporting date
30 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CABALETTA BIO, INC

Filing date
31 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

PIERIS PHARMACEUTICALS, INC.

Filing date
24 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

PASSAGE BIO, INC.

Filing date
29 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-22151

13F-HR filing

Filing date
15 Aug 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-22151

13F-HR filing

Filing date
16 May 2022
Reporting date
31 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

ALPINE IMMUNE SCIENCES, INC.

Filing date
22 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .